Loading clinical trials...
Loading clinical trials...
AIDA - A Digital Health Intervention Based on Artificial Intelligence to Support the Personalized Recovery of Long COVID Patients: Feasibility Study.
The AIDA feasibility study builds upon mental health and technology acceptance theoretical frameworks. It examines the feasibility of a mobile-based digital program to support patients with long covid affected by fatigue. The program Adhera ® Fatigue Self-management is adapted for long covid patients.
The study will explore the usability and engagement of a digital program designed for long covid patients affected by fatigue. The digital program relies on the Adhera® personalized digital health solution that includes personalized patient education and support, monitoring using psychometrics and wearables, and mental wellbeing exercises. The patients access the mobile solution via a mobile app. A total of 15 patients will be recruited and use the mobile solution for one month.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Gerencia Territorial de la Catalunya Central - Institut Catala de la Salut
Sant Fruitós de Bages, Catalonia, Spain
Start Date
August 1, 2022
Primary Completion Date
August 28, 2022
Completion Date
August 28, 2022
Last Updated
September 22, 2022
15
ACTUAL participants
Adhera® Fatigue for Long COVID program
BEHAVIORAL
Lead Sponsor
Adhera Health, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions